OVID THERAPEUTICS
Ovid is a pure play neurology company focused on rare and orphan diseases of the brain. They were founded in 2014 to leverage recent advances in science and medicine to find optimal therapies. They seek to identify and develop late stage, de-risked medicines with significant potential. Their rationale for developing these medicines is based on key insights from their scientific founders and confirmed in discussions with leading experts in the field. Their products are protected by strong intellectual property. They apply the most efficient processes to bring safe and effective therapies to patients. They are based in New York City but have collaborators and are working with patients across the United States and the globe.
OVID THERAPEUTICS
Industry:
Biopharma Biotechnology Health Care
Founded:
2014-01-01
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.ovidrx.com
Total Employee:
11+
Status:
Active
Contact:
(212) 776-4381
Email Addresses:
[email protected]
Total Funding:
134.12 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Wordpress Plugins Mobile Non Scaleable Content
Similar Organizations
Arbutus Biopharma
Arbutus Biopharma Corporation is a publicly-traded biopharmaceutical company.
Celsius Therapeutics
Celsius Therapeutics is a biotechnology company that develops precision medicines for cancer and autoimmune disease patients.
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
Imara
Imara is provider of novel therapeutics for the people living with sickle cell disease and hemoglobinopathies.
Minerva Neuroscience
Minerva Neurosciences is a clinical-stage biopharmaceutical company
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Current Employees Featured
Founder
Stock Details
Investors List
Sphera Funds Management
Sphera Funds Management investment in Series B - Ovid Therapeutics
Jennison Associates
Jennison Associates investment in Series B - Ovid Therapeutics
Redmile Group
Redmile Group investment in Series B - Ovid Therapeutics
Tekla Capital Management
Tekla Capital Management investment in Series B - Ovid Therapeutics
Fidelity Management and Research Company
Fidelity Management and Research Company investment in Series B - Ovid Therapeutics
DoubleLine Equity Healthcare Fund
DoubleLine Equity Healthcare Fund investment in Series B - Ovid Therapeutics
Sanofi Ventures
Sanofi Ventures investment in Series B - Ovid Therapeutics
Cormorant Asset Management
Cormorant Asset Management investment in Series B - Ovid Therapeutics
Official Site Inspections
http://www.ovidrx.com Semrush global rank: 50.69 K Semrush visits lastest month: 2.39 M
- Host name: 230.95.196.35.bc.googleusercontent.com
- IP address: 35.196.95.230
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York